Literature DB >> 28502089

Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Vanessa R Ribeiro1, Mariana Romao-Veiga2, Graziela G Romagnoli2, Mariana L Matias1, Priscila R Nunes1, Vera Therezinha M Borges1, Jose C Peracoli1, Maria Terezinha S Peracoli2.   

Abstract

Pre-eclampsia (PE) is an obstetric pathology characterized by abnormal activation of the innate and adaptive immune systems dependent on the imbalance of T helper subsets. The present study aimed to evaluate the gene and protein expression of T helper type 1 (Th1)/Th2/Th17/regulatory T (Treg) cell transcription factors in peripheral blood lymphocytes from pregnant women with PE employing quantitative RT-PCR and flow cytometry techniques, as well as the cytokine profile produced by these CD4+ T-cell subsets in the plasma of pregnant women with PE, classified as early-onset PE (n = 20), late-onset PE (n = 20) and normotensive pregnant women (n = 20). Results showed a higher percentage of CD4+ T cells expressing the RORc transcription factor (Th17) and a lower percentage of cells expressing FoxP3 (Treg) in women with early-onset PE compared with late-onset PE and normotensive groups. A lower gene expression of GATA-3 transcription factor was detected in cells of women with early-onset PE compared with the late-onset PE group. Endogenous plasma levels of interleukin-6 (IL-6), IL-17 and tumour necrosis factor-α were significantly higher in the early-onset PE group than in the late-onset PE and normotensive groups, whereas IL-4 (Th2 profile) and IL-22 (Th17 profile), were not significantly different between the studied groups. The endogenous levels of transforming growth factor-β and IL-10 were significantly lower in the pre-eclamptic than in the normotensive groups of the same gestational age, with a significant difference between early- and late-onset PE. The results show that in women with PE there is an imbalance between inflammatory and anti-inflammatory profiles in CD4+ T-cell subsets, with polarization to Th17 profiles in the early-onset PE, considered as the severe form of PE.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; cytokines; regulatory T cells; reproductive immunology; transcription factors

Mesh:

Substances:

Year:  2017        PMID: 28502089      PMCID: PMC5543493          DOI: 10.1111/imm.12757

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  58 in total

Review 1.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

Authors:  Casey T Weaver; Robin D Hatton
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 2.  Plasticity of T-cell phenotype and function: the T helper type 17 example.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Immunology       Date:  2009-11-17       Impact factor: 7.397

3.  Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women.

Authors:  Maria T S Peraçoli; Camila F Bannwart; Renata Cristofalo; Vera T Medeiros Borges; Roberto A Araújo Costa; Steven S Witkin; José C Peraçoli
Journal:  Am J Reprod Immunol       Date:  2011-05-27       Impact factor: 3.886

4.  The Expression of T-Helper Associated Transcription Factors and Cytokine Genes in Pre-Eclampsia.

Authors:  Behrouz Gharesi-Fard; Fatemeh Mobasher-Nejad; Fatemeh Nasri
Journal:  Iran J Immunol       Date:  2016-12       Impact factor: 1.603

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 6.  Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells.

Authors:  J Alijotas-Reig; E Llurba; J Ma Gris
Journal:  Placenta       Date:  2014-02-14       Impact factor: 3.481

7.  Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women.

Authors:  R Cristofalo; C F Bannwart-Castro; C G Magalhães; V T M Borges; J C Peraçoli; S S Witkin; M T Peraçoli
Journal:  Free Radic Res       Date:  2013-02-05

8.  CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4+CD25+ regulatory T cells and inducing indoleamine 2,3-dioxygenase.

Authors:  Weihong Li; Bin Li; Wei Fan; Lihong Geng; Xiaohong Li; Lei Li; Zhongying Huang; Shangwei Li
Journal:  J Reprod Immunol       Date:  2009-04-11       Impact factor: 4.054

9.  The relationship of hypovitaminosis D and IL-6 in preeclampsia.

Authors:  Lai Xu; Minjae Lee; Arun Jeyabalan; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2013-09-29       Impact factor: 8.661

10.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

View more
  18 in total

1.  Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Authors:  Corbin A Shields; Maggie McCalmon; Tarek Ibrahim; Dakota L White; Jan M Williams; Babbette LaMarca; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-02       Impact factor: 3.619

Review 2.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

3.  Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.

Authors:  Priscila R Nunes; Mariana Romão-Veiga; José C Peraçoli; Roberto A Araujo Costa; Leandro G de Oliveira; Vera Therezinha M Borges; Maria Terezinha Peraçoli
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

4.  Prenatal complications are associated with the postnatal airway host response and microbiota in intubated preterm infants.

Authors:  Brandie D Wagner; Marci K Sontag; J Kirk Harris; Joshua I Miller; Lindsey Morrow; Charles E Robertson; Mark J Stephens; Brenda B Poindexter; Steven H Abman; Peter M Mourani
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-28

5.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis.

Authors:  Meryl C Nath; Hajrunisa Cubro; Daniel J McCormick; Natasa M Milic; Vesna D Garovic
Journal:  Hypertension       Date:  2020-10-26       Impact factor: 10.190

Review 6.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

7.  Mid-pregnancy maternal blood nitric oxide-related gene and miRNA expression are associated with preterm birth.

Authors:  Tracy A Manuck; Lauren A Eaves; Julia E Rager; Rebecca C Fry
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

Review 8.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

9.  Nitric oxide-related gene and microRNA expression in peripheral blood in pregnancy vary by self-reported race.

Authors:  Tracy A Manuck; Lauren A Eaves; Julia E Rager; Karen Sheffield-Abdullah; Rebecca C Fry
Journal:  Epigenetics       Date:  2021-07-24       Impact factor: 4.861

10.  Preeclampsia: From Inflammation to Immunoregulation.

Authors:  Denise C Cornelius
Journal:  Clin Med Insights Blood Disord       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.